Acute myeloid leukemia (AML) is definitely a phenotypically and prognostically heterogeneous hematopoietic stem cell disease that may be cured in eligible patients with extensive chemotherapy and/or allogeneic stem cell transplantation (allo-SCT). span of disease and based on disease and risk position up to half of these will finally relapse after transplant. Right here we review… Continue reading Acute myeloid leukemia (AML) is definitely a phenotypically and prognostically heterogeneous